Chimeric peptides as implant functionalization agents for titanium alloy implants with antimicrobial properties

Area of Science:

• Biomaterials Science
• Infectious Diseases
• Nanotechnology

Background:

• Implant-associated infections lead to device failure and are difficult to treat with antibiotics due to poor penetration and rising antibiotic resistance.
• Antimicrobial peptides (AMPs) are promising therapeutic agents due to their ability to stimulate innate immunity and low resistance development.
• Controlling the bio-material interface is crucial for preventing infections and ensuring implant longevity.

Purpose of the Study:

• To develop and evaluate a novel chimeric peptide for functionalizing implant surfaces.
• To create a peptide with dual functionality: binding to titanium alloy and exhibiting antimicrobial activity.
• To assess the efficacy of the chimeric peptide against common implant-associated bacteria.

Main Methods:

• A chimeric peptide was designed with a titanium-binding domain and an antimicrobial domain.
• The peptide was used to functionalize a titanium alloy surface.
• In vitro studies evaluated the peptide's efficacy in solution and on the functionalized surface against *S. mutans*, *S. epidermidis*, and *E. coli*.

Main Results:

• The chimeric peptide demonstrated antimicrobial activity in solution.
• The peptide effectively adhered to the titanium alloy surface via its binding domain.
• The functionalized surface showed efficacy in inhibiting bacterial growth, indicating successful prevention of implant-associated infections.

Conclusions:

• Chimeric peptides offer a novel approach to create antibacterial implant surfaces.
• Functionalizing implant materials with these peptides can control bio-material interfaces and prevent infections.
• This strategy holds potential for improving implant longevity and patient outcomes.